The untapped potential of ascites in ovarian cancer research and treatment

CE Ford, B Werner, NF Hacker, K Warton - British journal of cancer, 2020 - nature.com
The build-up of fluid in the peritoneal cavity—ascites—is a hallmark of ovarian cancer, the
most lethal of all gynaecological malignancies. This remarkable fluid, which contains a …

[HTML][HTML] Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment

E Schoutrop, L Moyano-Galceran, S Lheureux… - Seminars in cancer …, 2022 - Elsevier
Ovarian cancer encompasses a heterogeneous group of malignancies that involve the
ovaries, fallopian tubes and the peritoneal cavity. Despite major advances made within the …

[HTML][HTML] SCD1/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells

Y Xuan, H Wang, MMH Yung, F Chen, WS Chan… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Malignant ascites in peritoneal metastases is a lipid-enriched microenvironment
and is frequently involved in the poor prognosis of epithelial ovarian cancer (EOC) …

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment

OO Yeku, TJ Purdon, M Koneru, D Spriggs… - Scientific reports, 2017 - nature.com
Chimeric antigen receptor (CAR) T cell therapy has shown limited efficacy for the
management of solid tumor malignancies. In ovarian cancer, this is in part due to an …

Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response

BP Rickard, C Conrad, AJ Sorrin, MK Ruhi, JC Reader… - Cancers, 2021 - mdpi.com
Simple Summary Accumulation of excess fluid in the abdomen typically indicates abnormal
function or disease, such as cancer, in the underlying tissues. This accumulation of fluid, or …

[HTML][HTML] Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer

W Wang, HA Jo, S Park, H Kim, SI Kim, Y Han, J Lee… - Cancer letters, 2022 - Elsevier
Ovarian cancer is mostly diagnosed at advantaged stages due to the lack of early diagnostic
biomarkers. The common metastasis pattern is characterized by peritoneal dissemination …

Tumor evolution and chemoresistance in ovarian cancer

S Kim, Y Han, SI Kim, HS Kim, SJ Kim… - NPJ precision oncology, 2018 - nature.com
Abstract Development of novel strategies to overcome chemoresistance is central goal in
ovarian cancer research. Natural history of the cancer development and progression is …

Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer

S Al Habyan, C Kalos, J Szymborski, L McCaffrey - Oncogene, 2018 - nature.com
Ovarian cancer is the most lethal gynecological cancer, where survival rates have had
modest improvement over the last 30 years. Metastasis of cancer cells is a major clinical …

Deregulation of lipid metabolism: the critical factors in ovarian cancer

Z Ji, Y Shen, X Feng, Y Kong, Y Shao, J Meng… - Frontiers in …, 2020 - frontiersin.org
Ovarian cancer is one of the most malignant gynecological cancers around the world. In
spite of multiple treatment options, the five-year survival rate is still very low. Several …

Ovarian cancer stem cells: still an elusive entity?

M Lupia, U Cavallaro - Molecular cancer, 2017 - Springer
The cancer stem cell (CSC) model proposes that tumor development and progression are
fueled and sustained by undifferentiated cancer cells, endowed with self-renewal and tumor …